S1 Guidelines for the Kaposi Sarcoma.


Journal

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708

Informations de publication

Date de publication:
06 2022
Historique:
received: 22 12 2021
accepted: 10 03 2022
pubmed: 4 6 2022
medline: 22 6 2022
entrez: 3 6 2022
Statut: ppublish

Résumé

Kaposi's sarcoma (KS) is a rare, malignant, multilocular vascular disease originating from lymphatic endothelial cells that can primarily affect the skin and mucous membranes, but also the lymphatic system and internal organs such as the gastrointestinal tract, lungs or liver. Five epidemiological subtypes of KS with variable clinical course and prognosis are distinguished, with increased incidence in specific populations: (1) Classical KS, (2) Iatrogenic KS in immunosuppression, (3) Endemic (African) lymphadenopathic KS, (4) Epidemic, HIV-associated KS and KS associated with immune reconstitution inflammatory syndrome (IRIS), and (5) KS in men who have sex with men (MSM) without HIV infection. This interdisciplinary guideline summarizes current practice-relevant recommendations on diangostics and therapy of the different forms of KS. The recommendations mentioned in this short guideline are elaborated in more detail in the extended version of the guideline (online format of the JDDG).

Identifiants

pubmed: 35657085
doi: 10.1111/ddg.14788
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

892-904

Informations de copyright

© 2022 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.

Auteurs

Stefan Esser (S)

HPSTD Outpatient Clinic, University Hospital of Dermatology Essen, University of Duisburg-Essen, Essen, Germany.
Institute for Translational HIV Research, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Helmut Schöfer (H)

Helios Dr. Horst Schmidt Kliniken, German Clinic for Diagnostics, Wiesbaden, Germany.

Christian Hoffmann (C)

ICH Study Center Hamburg, Hamburg, Germany.
Medical Clinic II, University of Schleswig-Holstein, Kiel Campus, Kiel, Germany.

Johannes Claßen (J)

Clinic for Radiotherapy, Radiological Oncology and Palliative Medicine, ViDia Christian Clinics Karlsruhe, Karlsruhe, Germany.

Alexander Kreuter (A)

Clinic for Dermatology, Venerology and Allergology, HELIOS St.-Elisabeth Hospital Oberhausen, University of Witten-Herdecke, Germany.

Ulrike Leiter (U)

Center for Dermatooncology, University Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.

Mark Oette (M)

Clinic for General Internal Medicine, Gastroenterology, Infectiology, Augustinian Sisters Hospital, Cologne, Germany.

Jürgen C Becker (JC)

Translational Skin Cancer Research, German Consortium for Translational Cancer Research (DKZK), University Medical Center Essen, Essen, Germany.
Clinic for Dermatology, University Hospital Essen, Essen, Germany.
German Cancer Research Institute (DKFZ), Heidelberg, Germany.

Mirjana Ziemer (M)

Clinic for Dermatology, Venereology and Allergology, University Hospital Leipzig, Leipzig, Germany.

Franz Mosthaf (F)

Joint Practice for Hematology, Oncology and Infectiology Karlsruhe, Karlsruhe, Germany.

Judith Sirokay (J)

Clinic and Polyclinic for Dermatology and Allergology, University Hospital Bonn, Bonn, Germany.

Selma Ugurel (S)

Clinic for Dermatology, Venereology and Allergology, University Hospital Essen, Essen, Germany.

Anja Potthoff (A)

WIR- Walk In Ruhr, Center for Sexual Health and Medicine, Clinic for Dermatology, Venerology and Allergology, Ruhr- University Bochum, Germany.

Doris Helbig (D)

Clinic and Polyclinic for Dermatology and Venereology, University Hospital Cologne, Cologne, Germany.

Erhard Bierhoff (E)

Heinz Werner Seifert Institute for Dermatopathology Bonn, Bonn, Germany.

Thomas F Schulz (TF)

Institute of Virology, Hannover Medical School, Hannover, Germany.

Norbert H Brockmeyer (NH)

WIR- Walk In Ruhr, Center for Sexual Health and Medicine, Clinic for Dermatology, Venerology and Allergology, Ruhr- University Bochum, Germany.

Stephan Grabbe (S)

Department of Dermatology, University Medical Center Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH